BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1504755)

  • 1. Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions.
    Pöch G; Brunner F; Kühberger E
    Br J Pharmacol; 1992 Jul; 106(3):710-6. PubMed ID: 1504755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental and theoretical comparisons between the classical Schild analysis and a new alternative method to evaluate the pA2 of competitive antagonists.
    Calderone V; Baragatti B; Breschi MC; Martinotti E
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):477-87. PubMed ID: 10598787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculating slope and ED50 of additive dose-response curves, and application of these tabulated parameter values.
    Pöch G; Pancheva SN
    J Pharmacol Toxicol Methods; 1995 Jun; 33(3):137-45. PubMed ID: 7640393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonist inhibition curves and the measurement of dissociation constants.
    Barlow RB; Bond SM; Bream E; Macfarlane L; McQueen DS
    Br J Pharmacol; 1997 Jan; 120(1):13-8. PubMed ID: 9117087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
    Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Schild regression in the process of receptor classification.
    Kenakin TP
    Can J Physiol Pharmacol; 1982 Mar; 60(3):249-65. PubMed ID: 7042056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations.
    Cheng HC
    J Pharmacol Toxicol Methods; 2001; 46(2):61-71. PubMed ID: 12481843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New methods for determining dissociation constants of agonist-receptor complexes.
    Venter DP
    Eur J Pharmacol; 1996 May; 303(3):235-46. PubMed ID: 8813575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
    Hussain MB; Marshall I
    Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding profiles of class I antiarrhythmic agents to cardiac muscarinic receptors: competitive and allosteric interactions with the receptors and their pharmacological significance.
    Endou M; Gando S; Hattori Y; Kanno M
    J Pharmacol Exp Ther; 1991 Sep; 258(3):992-8. PubMed ID: 1890628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple pA2 estimation of partial agonists: comparison with the Kaumann-Blinks method.
    Pöch G; Zimmermann I
    J Pharmacol Methods; 1988 Mar; 19(1):47-56. PubMed ID: 3367648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations.
    Lazareno S; Birdsall NJ
    Br J Pharmacol; 1993 Aug; 109(4):1110-9. PubMed ID: 8401922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the use of a dynamic approach to the estimation of dissociation constants for reversible competitive antagonists.
    Amidon GL; Buckner CK
    J Pharmacol Exp Ther; 1981 Feb; 216(2):352-6. PubMed ID: 6257889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developments of computer-based estimation of pA2 values and associated analysis.
    Stone M; Angus JA
    J Pharmacol Exp Ther; 1978 Dec; 207(3):705-18. PubMed ID: 731426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of competitive antagonist affinity by the Schild method and from functional inhibition curves using a novel form of the Gaddum equation.
    Ezechiáš M; Cajthaml T
    Toxicology; 2019 May; 420():21-28. PubMed ID: 30935971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.
    Cheng HC
    Pharmacol Res; 2004 Jul; 50(1):21-40. PubMed ID: 15082026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2 muscarinic receptor-mediated inhibition of the Ca2+ current in rat magnocellular cholinergic basal forebrain neurones.
    Allen TG; Brown DA
    J Physiol; 1993 Jul; 466():173-89. PubMed ID: 8410690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptor subtypes controlling the cationic current in guinea-pig ileal smooth muscle.
    Zholos AV; Bolton TB
    Br J Pharmacol; 1997 Nov; 122(5):885-93. PubMed ID: 9384504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.